Kerrisdale Capital Releases Negative Report on Proteostasis Therapeutics, Inc.

Sahm Adrangi’s company, Kerrisdale Capital, released a unfavorable report on some of the recent findings of the Proteostasis Therapeutics, Inc. company. Proteostasis Therapeutics, Inc. (PTI) is a biopharmaceutical company that works to develop new drugs and test them clinically. PTI’s lead drug in development is called PTI-428. This drug is intended to treat the effects of cystic fibrosis by boosting the messenger RNA and proteins to the CFTR gene that is believed to cause these debilitating effects, effects which are eventually fatal.

In December, PTI released results from a trial that seemed to show the drug was working. The stock market responded to these findings with approximately a 100% jump in the company’s stock prices. The FDA even granted the drug a “breakthrough therapy” designation based on the report. Sahm Adrangi’s firm decided to take a closer look at the results of the trial. The trial seemed to show the effectiveness of the drug when it compared the test group and a placebo/control group. The report released by Sahm Adrangi’s firm, Kerrisdale Capital, said that the the test group didn’t exactly do unusually well, but that rather the control group under-performed. When compared to proper benchmarks, the drug actually had little to no effect. The unbalanced report issued by PTI is Phase 2 of testing. Their Phase 1 report showed much the same that Kerrisdale Capital found: no statistically-proven improvement.

Sahm Adrangi founded Kerrisdale Capital in 2009 and remains its Chief Financial Officer. In the past, his firm has exposed fraudulent findings from several Chinese medical companies. Sahm Adrangi’s reports have to lead to those companies receiving enforcement actions from the Securities and Exchange Commission.

Sahm Adrangi’s report concerning PTI said the company had “little value” and that there was a 70% – 90% downside to purchasing their stock. As seen with other companies in the past, PTI may become subject to enforcement and loss of stock value due to Kerrisdale Capital taking a second look.

https://seekingalpha.com/article/4052332-conversation-former-hedge-fund-analyst-long-shares-gnc

Ian King: Leading in Cryptocurrency Insights

With the latest trends in blockchain technology and cryptocurrencies, the investment world is shaken and is looking for solid insights about how to go around this new horizon. Banyan Hill Publishing houses one of the best experts in cryptocurrency, Ian King, who shares weekly insights about the newest forms of investments. Learn more about Ian King at Crunchbase.

About Ian King

Ian King is a well-known cryptocurrency investor and a former hedge fund expert. He has 20 years of experience in trading and giving insights into financial matters. One of his most sought-after financial advisings is his knowledge and expertise in cryptocurrency market. It has been featured in several known publications such as Zero Hedge, Seeking Alpha, Fox Business News and Investopedia. His expertise allowed him to be one of the senior analysts in Banyan Hill Publishing. At present, he has created a cryptocurrency investment product for his course in Investopedia Academy.

Ian King had an initial career of being a desk clerk at Salomon Brothers. Salomon Brothers is a known mortgage bond trading department, and this is where Ian King started learning his investment skills. He then moved to work for Citigroup as a credit derivatives specialist. He spent 10 years knowing the ins and outs of trading, as he moved as a head trader in Peahi Capital, a hedge fund company based in New York.

After working for Peahi Capital, Mr. Ian King went to Banyan Hill Publishing as an investment expert. He had to goal to help readers start their investments on cryptocurrency. At present, he is the editor of the popular newsletter Crypto Profit Trader service, one of Banyan Hill’s advisory newsletter that shows the best cryptocurrency trends to help readers make the best financial decisions. Ian King is also a regular contributor to the Sovereign Investor Daily wherein he specializes in the latest advancements in cryptocurrency. Visit the website iankingguru.com to learn more.

More of Ian King’s Writings in Medium

Aside from Banyan Hill Publishing, Ian King also contributes to the online platform Medium, where he talks about the latest trends in cryptocurrency.

One of his latest topics was the ‘cryptocorn’, where he explains that only a handful of startup ideas had a large growth in revenue in the past years. He compares startups such as Uber, Airbnb, and Pinterest to other ones such as Blue Apron and Snapchat. He mentioned that the rise of cryptocurrencies is far ahead compared to these startups because of the 1000% increase in its value over a short period of time.

View: https://hitechchronicle.com/2018/03/ian-king-says-robinhood-could-help-cryptocurrency-values-soar/

Ian King’s insights can be visited on his Medium page.